SE445345B - Monohydratet av 1alfa,25-dihyroxi-cholekalciferol samt farmaceutiska kompositioner innehallande denna forening - Google Patents
Monohydratet av 1alfa,25-dihyroxi-cholekalciferol samt farmaceutiska kompositioner innehallande denna foreningInfo
- Publication number
- SE445345B SE445345B SE8002244A SE8002244A SE445345B SE 445345 B SE445345 B SE 445345B SE 8002244 A SE8002244 A SE 8002244A SE 8002244 A SE8002244 A SE 8002244A SE 445345 B SE445345 B SE 445345B
- Authority
- SE
- Sweden
- Prior art keywords
- cholecalciferol
- pharmaceutical compositions
- compound
- 1alfa
- dihyroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7913118A FR2457282A1 (fr) | 1979-05-23 | 1979-05-23 | Nouveau derive du 1a,25 dihydroxy cholecalciferol, son procede de preparation et son application comme medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8002244L SE8002244L (sv) | 1980-11-24 |
SE445345B true SE445345B (sv) | 1986-06-16 |
Family
ID=9225772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8002244A SE445345B (sv) | 1979-05-23 | 1980-03-24 | Monohydratet av 1alfa,25-dihyroxi-cholekalciferol samt farmaceutiska kompositioner innehallande denna forening |
Country Status (19)
Country | Link |
---|---|
US (1) | US4435325A (de) |
JP (1) | JPS55160758A (de) |
AT (1) | AT371434B (de) |
AU (1) | AU530140B2 (de) |
BE (1) | BE883435A (de) |
CA (1) | CA1140155A (de) |
CH (1) | CH646146A5 (de) |
DE (1) | DE3019885A1 (de) |
ES (1) | ES8102092A1 (de) |
FR (1) | FR2457282A1 (de) |
GB (1) | GB2051818B (de) |
GR (1) | GR68548B (de) |
HU (1) | HU182137B (de) |
IL (1) | IL59857A (de) |
IT (1) | IT1145684B (de) |
NL (1) | NL8003001A (de) |
PT (1) | PT71293B (de) |
SE (1) | SE445345B (de) |
ZA (1) | ZA802389B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634692A (en) * | 1981-08-28 | 1987-01-06 | Hoffmann-La Roche Inc. | Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol |
US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
USRE33107E (en) * | 1983-03-22 | 1989-11-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
US4769181A (en) * | 1983-11-07 | 1988-09-06 | Wisconsin Alumni Research Foundation | 1,25-dihydroxyvitamin D2 compounds |
USRE39706E1 (en) * | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3833622A (en) * | 1969-03-17 | 1974-09-03 | Upjohn Co | Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds |
US3697559A (en) * | 1971-02-25 | 1972-10-10 | Wisconsin Alumni Res Found | 1,25-dihydroxycholecalciferol |
JPS4934980A (de) * | 1972-08-04 | 1974-03-30 | ||
US3901928A (en) * | 1973-01-10 | 1975-08-26 | Robert Henry Hesse | 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds |
US3993675A (en) * | 1975-02-24 | 1976-11-23 | Hoffmann-La Roche Inc. | Process for the preparation of 1α,25-dihydroxycholecalciferol |
JPS51100056A (en) * | 1975-02-28 | 1976-09-03 | Chugai Pharmaceutical Co Ltd | 1 arufua 255 jihidorokishikorekarushifuerooruno seiho |
US4022768A (en) * | 1976-02-12 | 1977-05-10 | Wisconsin Alumni Research Foundation | Process for preparation of 1α,25-dihydroxycholecalciferol |
-
1979
- 1979-05-23 FR FR7913118A patent/FR2457282A1/fr active Granted
-
1980
- 1980-03-24 SE SE8002244A patent/SE445345B/sv not_active IP Right Cessation
- 1980-04-17 IL IL59857A patent/IL59857A/xx unknown
- 1980-04-21 ZA ZA00802389A patent/ZA802389B/xx unknown
- 1980-05-05 US US06/146,497 patent/US4435325A/en not_active Expired - Lifetime
- 1980-05-20 HU HU801252A patent/HU182137B/hu not_active IP Right Cessation
- 1980-05-21 GR GR62007A patent/GR68548B/el unknown
- 1980-05-21 AU AU58627/80A patent/AU530140B2/en not_active Ceased
- 1980-05-22 GB GB8016893A patent/GB2051818B/en not_active Expired
- 1980-05-22 CA CA000352534A patent/CA1140155A/fr not_active Expired
- 1980-05-22 CH CH402080A patent/CH646146A5/fr not_active IP Right Cessation
- 1980-05-22 PT PT71293A patent/PT71293B/pt not_active IP Right Cessation
- 1980-05-22 BE BE0/200723A patent/BE883435A/fr not_active IP Right Cessation
- 1980-05-22 ES ES491732A patent/ES8102092A1/es not_active Expired
- 1980-05-22 IT IT48763/80A patent/IT1145684B/it active
- 1980-05-23 DE DE19803019885 patent/DE3019885A1/de active Granted
- 1980-05-23 JP JP6798480A patent/JPS55160758A/ja active Pending
- 1980-05-23 NL NL8003001A patent/NL8003001A/nl not_active Application Discontinuation
- 1980-05-23 AT AT0278780A patent/AT371434B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR68548B (de) | 1982-01-18 |
SE8002244L (sv) | 1980-11-24 |
NL8003001A (nl) | 1980-11-25 |
GB2051818A (en) | 1981-01-21 |
FR2457282A1 (fr) | 1980-12-19 |
FR2457282B1 (de) | 1983-10-28 |
CH646146A5 (fr) | 1984-11-15 |
CA1140155A (fr) | 1983-01-25 |
AU5862780A (en) | 1980-11-27 |
PT71293A (fr) | 1980-06-01 |
IL59857A (en) | 1983-12-30 |
IT1145684B (it) | 1986-11-05 |
HU182137B (en) | 1983-12-28 |
GB2051818B (en) | 1983-06-29 |
PT71293B (fr) | 1981-09-21 |
DE3019885C2 (de) | 1990-04-05 |
IL59857A0 (en) | 1980-06-30 |
IT8048763A0 (it) | 1980-05-22 |
AU530140B2 (en) | 1983-07-07 |
JPS55160758A (en) | 1980-12-13 |
ZA802389B (en) | 1981-04-29 |
DE3019885A1 (de) | 1980-11-27 |
ES491732A0 (es) | 1980-12-16 |
US4435325A (en) | 1984-03-06 |
BE883435A (fr) | 1980-11-24 |
ATA278780A (de) | 1982-11-15 |
ES8102092A1 (es) | 1980-12-16 |
AT371434B (de) | 1983-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3268379B1 (de) | Kristalline form von nicotinamid-ribosid | |
US5536504A (en) | Ultramicroemulsions from spontaneously dispersible concentrates containing xanthophyll esters and having antitumor activity | |
DE2400931C2 (de) | ||
DE69233074T2 (de) | Verfahren zur Herstellung von 1-alpha-24-dihydroxy-Vitamin D2 | |
HU194285B (en) | Process for preparing inclusion compound formed from 2-/nitrooxymethyl/-6-chlorpyridine and beta-cyclodextrin | |
DE2821242C2 (de) | ||
JPS63159385A (ja) | マロン酸誘導体及びその製法並びにその用途 | |
IE912973A1 (en) | Codeine salt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations | |
EP0036663A1 (de) | Oxiranbuttersäure-Derivate, ihre Herstellung und Verwendung, sowie diese enthaltende Arzneimittel | |
SE445345B (sv) | Monohydratet av 1alfa,25-dihyroxi-cholekalciferol samt farmaceutiska kompositioner innehallande denna forening | |
NL8420137A (nl) | Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. | |
EP0010156B1 (de) | 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung | |
NZ191899A (en) | 24,24-difluoro-25-hydroxy-vitamin d3 and 24,24-difluoro-25-hydroxy-previtamin d3;pharmaceutical compositions | |
NZ205785A (en) | Intermediates in the preparation of 1-hydroxy-2 fluorocholecalciferol and related compounds | |
DE69318142T2 (de) | 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 | |
DE3787971T2 (de) | Aktives prinzip, isoliert aus haigeweben. | |
FR2545824A1 (fr) | Derive 1a, 25-dihydroxyles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives | |
EP0276573A2 (de) | Verwendung von 24,25-Dihydroxycholecalciferol zur Verhütung des Knochenalterns | |
US4511564A (en) | Methods of controlling the concentration of calcium in the serum of warm-blooded animals and pharmaceutical compositions to be used therefor | |
JPH10237093A (ja) | マツホド抽出成分を含む抗炎症剤 | |
EP0051193A1 (de) | Verwendung von N-halogenphenyl-benzisothiazolen | |
JP2009520813A (ja) | カルバメート系抗生物質 | |
DD275689A5 (de) | Verfahren zur herstellung von enolethern von 6-chlor-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazin-3-carbonsaeureamid-1,1-dioxid | |
WO2000001380A1 (de) | Cyclooxygenaseinhibitor | |
US3337561A (en) | Process for obtaining alkaloids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8002244-5 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8002244-5 Format of ref document f/p: F |